Seminar Title: “Technological Advancements for Accelerated Development of Effective nanomedicines”
Wednesday, February 2, 2022 from 3:30 – 4:30 – WebEx
https://uconn-cmr.webex.com/uconn-cmr/j.php?MTID=m2ca90e4e108d1a3457daee935c39904b
Dr. Christine Allen is the Associate Vice-President and Vice-Provost, Strategic Initiatives at the University of Toronto and a full professor in the Leslie Dan Faculty of Pharmacy. She is the CEO and Scientific Director of the Nanomedicines Innovation Network, a National Centre of Excellence funded by the Government of Canada. Her research focuses on the design of innovative materials and drug delivery technologies with over 150 publications in this area. She is the co-founder and served as President of Nanovista Inc., a company focused on high-precision, image-guided cancer therapy. Professor Allen is a fellow of the American Institute for Medical and Biological Engineering, the Controlled Release Society (CRS) and the Canadian Academy of Health Sciences. She is the Editor-in-Chief of the Journal of Controlled Release, the President-Elect of the CRS and an appointed member of the Governing Council of the Natural Sciences and Engineering Research Council of Canada.
For more information, contact: Diane Burgess at d.burgess@uconn.edu